Pierpaolo POMPA
Pierpaolo POMPA
(Italian Institute of Technology, Ehs Unit)
Pier Paolo Pompa is a tenured Senior Scientist and Head of the Nanobiointeractions&Nanodiagnostics research group of Istituto Italiano di Tecnologia (IIT). After his degree in Physics, in 2005 he took a PhD in Nanoscience at the National Nanotechnology Laboratory (NNL) in Lecce. PPP subsequently joined NNL as a junior researcher and, since February 2008, as a staff scientist. In 2009 he moved to the Center for Biomolecular Nanotechnologies (CBN) of IIT, where he was first appointed Coordinator of the Environment, Health and Safety (EHS) Research Platform and in 2011 Director of CBN. In 2015 he moved to the Central Research Labs of IIT in Genova.
His scientific activities are highly interdisciplinary, ranging from nanotechnology to biophysics, nanodiagnostics, nanomedicine, nanobiotechnology and nanochemistry, and are intensively focused on the understanding of the interaction between nanomaterials and living systems. His current research interests deal with three main topics: the identification of the response of biological systems upon interaction with nanoscale materials, such as engineered nanoparticles and nanostructured substrates, and investigation of the underlying mechanisms; the development of low-cost hybrid sensing strategies, based on nanoparticles, for point-of-care diagnostics; the development of nanomaterials-based systems for nanomedicine, nanoimaging, and biomedical applications.
Pier Paolo Pompa has authored ca. 100 peer-reviewed publications in International Journals (including Nature Nanotechnology, PNAS, ACS Nano, Advanced Materials, Chem. Soc. Rev.), several book chapters, and many invited and oral contributions to International Conferences. He is also author of 16 Patents. He leads various national and international projects in the field of nanoscience and nanobiotechnology (he has been granted more than 5.5 M€ of external funds). He is also reviewer of major scientific journals (Nature Materials, Nature Nanotechnology, ACS Nano, etc.) and international funding agencies.
